NDRA ENDRA Life Sciences Inc.
-
ENDRA Life Sciences Beat Consensus Estimates
Friday, August 14, 2026 · 12:00 AM ET
ENDRA Life Sciences (NDRA) reported a loss of $0.63 per share on revenue of $0.00 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.84 per share on revenue of $0.20 million. The company beat consensus estimates by 25.00%.
ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.
Reported Earnings
($0.63)
Earnings Whisper®
—
Consensus Estimate
($0.84)
Earnings Surprise
Earnings Growth
Reported Revenue
—
Revenue Estimate
$0.20M
Revenue Surprise
Revenue Growth—